Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Astra will complement its products with embedded AI-based IS solutions

11/22/23 ASTR

Shareholders of Whoosh approved dividends for 9 months 2023

11/22/23 WUSH

UWC completed the placement of additional share issue

11/22/23 UWGN

HP reported for fiscal year 2023

11/22/23 HPQ

Transneft share split to take place in February 2024

11/22/23 TRNFP

IPO Yuzhuralzolot was at the lower end of the range

11/22/23 UGLD

NVIDIA announced a quarterly dividend

11/22/23 NVDA

Nvidia reported for 9 months of fiscal year 2024

11/22/23 NVDA

SPB Exchange will assess the volume of assets not subject to restrictions

11/21/23 SPBE

Driving school Svetofor reported for 9 months of 2023

11/21/23 SVET